Several studies examined the link between circulating irisin, adiposity, and obesity in humans but with inconsistent results, which may be explained by the fact that irisin may be involved in compensatory mechanism for altered metabolism in obesity and thereby different metabolic status of the specific obese individual determines its levels. This evidence concerns the gene FNDC5 and obesity disorder.